Survey: Half of docs less confident in Boston Scientific after defib hold

April 8, 2010 by MassDevice staff

A survey indicates that Boston Scientific's suspension of its defibrillator operations caused doctors' confidence in the company's products to plunge, with more than half of those polled saying they're less likely to use BSX devices in the future.

BSX logo

A survey of 70 electrophysiologists indicates that the impact of Boston Scientific Corp.'s (NYSE:BSX) suspension of its defibrillator operations last month will have long-lasting consequences for the medical device maker.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.